Back to Journals » Breast Cancer: Targets and Therapy » Aims and Scope
Breast Cancer: Targets and Therapy
Aims and Scope
Breast Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on breast cancer, basic and translational research, clinical trials and treatment. The latter includes outcome studies that incorporate preventative and integrated treatment strategies for enhanced survival, and quality of life for cancer patients.
Breast Cancer: Targets and Therapy will no longer consider meta-analyses for publication.
Specific topics covered in the journal include:
- Epidemiology, detection and screening
- Cellular research and biomarkers
- Cancer stem cells
- Cancer dormancy and metastasis
- Novel biotargets and other agents such as small non-coding RNA
- Drug Delivery Systems
- Optimal clinical use of existing anti-cancer agents, including combination therapies
- Radiation and surgery
- Palliative care
- Patient adherence, quality of life, satisfaction
- Health economic evaluations
The journal welcomes submitted papers covering original research articles, reviews, basic and translational research, clinical and epidemiological studies, treatment guidelines, expert opinion and commentaries.
Breast Cancer: Targets and Therapy will no longer consider case reports/series for publication.
When considering submission of a paper utilizing publicly available data (e.g. SEER/GWAS/TCGA/GEO etc.), authors should ensure that such studies add significantly to the body of knowledge about breast cancer or relevant phenotype and that they are validated using the authors’ own data through replication in an independent sample set and functional follow-up.
All papers submitted on or after 3 August 2022 must meet these requirements.